Jost Viebrock
- 2013-2018: studies mathematics at the University of Bremen (B.Sc.)
- 2018-2020: studies mathematics at the University of Bremen (M.Sc.)
- Since April 2021: Research Associate at BIPS
- Development of prescribing patterns for combined hormonal contraceptives in Germany after Dear Doctor Letters (Rote-Hand-Briefe) in December 2018 and September 2021
- Evaluation of the breast cancer mortality in the German Mammography Screening Program: Main study - 2nd part
- PAS-study for alemtuzumab
- PAS-study for Entresto® (sacubitril/valsartan)
- Study to analyze regional differences in antibiotic prescriptions
- The use of MS-medications in girls and women of childbearing age and during pregnancy in Germany
- Use of opioid-containing drugs in Germany
- Use of parenteral Iron-(III)-products in Germany
Articles with peer review
- Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Comparative analysis of outpatient antibiotic prescribing in early life: A population-based study across birth cohorts in Denmark and Germany. Infectious Diseases and Therapy. 2024;13(2):299-312.
https://doi.org/10.1007/s40121-024-00916-3 - Riedel O, Viebrock J, Haug U. Overall survival in 92,991 colorectal cancer patients in Germany: Differences according to type of comorbidity. Acta Oncologica. 2023;62(12):1931-1938.
https://doi.org/10.1080/0284186X.2023.2282120 Articles without peer review
- Reinold J, Viebrock J, Haug U. Verschreibung von parenteralen Eisen(III)-Präparaten in der ambulanten Arzneimittelversorgung in Deutschland. Bulletin zur Arzneimittelsicherheit - Informationen aus BfArM und PEI. 2023;4:4-9.
https://www.bfarm.de/DE/Aktuelles/Publikationen/Bulletin/Ausgaben/_node.html Presentations at scientific meetings/conferences
- Börnhorst C, Haug U, Kollhorst B, Viebrock J, Didelez V, Schäfer W. Breast cancer recurrence due to avoidable drug-drug interactions? Development of a protocol for emulating a target trial in women with breast cancer that concurrently use tamoxifen and antidepressants. Workshop der Arbeitsgemeinschaft Pharmakoepidemiologie der Deutschen Gesellschaft für Epidemiologie (DGEpi) und der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), 20.-21. Juni 2023, Bremen.
- Scholle O, Jobski K, Viebrock J, Haug U. Prescribing of opioid analgesics in Germany: Opposite trends when different quantification measures are used. 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 23-27 August 2023, Halifax, Canada. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2023;32(Supp. 1):102)
- Viebrock J, Didelez V. Adressing confounding of primary and competing events. Survival Analysis for Junior Researchers (SAfJR), 13-15 September 2023, Günzburg.
- Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Outpatient antibiotic prescribing in early life: A population-based study comparing birth cohorts from Denmark and Germany. 29. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA), 24.-25. November 2022, Münster.
Presentations at scientific meetings/conferences (invited)
- Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Ambulante Verordnung von Antibiotika im frühen Leben: Eine bevölkerungsbasierte Studie zum Vergleich von Geburtskohorten aus Dänemark und Deutschland. Runder Tisch des Multiresistente-Erreger-Netzwerks (MRE) im Land Bremen, 17. Januar 2024, Bremen.
Posters at scientific meetings/conferences
- Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Outpatient antibiotic prescribing in early life: A population-based study comparing birth cohorts from Denmark and Germany. 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 24-28 August 2022, Copenhagen, Denmark. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2022;31(Suppl. 2):470)
Selected BIPS-Publications
For further publications please follow this link:
Summer term 2021 Statistical Modelling II for Medical Biometry / Biostatistics, M.Sc. at the University of Bremen
Winter term 2021/22 Survival Analysis for Medical Biometry / Biostatistics, M.Sc. at the University of Bremen
Summer term 2023 Statistical Modelling II for Medical Biometry / Biostatistics, M.Sc. at the University of Bremen
Winter term 2021/22 Survival Analysis for Medical Biometry / Biostatistics, M.Sc. at the University of Bremen
Summer term 2023 Statistical Modelling II for Medical Biometry / Biostatistics, M.Sc. at the University of Bremen
The responsibility for the content of this page lies with Jost Viebrock.